Search Results 1831-1840 of 14804 for anti-TNF drugs

  1. STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Prior therapy with immune checkpoint inhibitors (e.g., anti-CTLA4, ...

  2. SDF1 Plasmid Treatment for Patients With Peripheral Artery Disease - Mayo Clinic

    About this study. To investigate the efficacy of the administration of JVS-100 delivered via direct intramuscular injections on a 3 month and 6 month ...

  3. Sulfamethoxazole And Trimethoprim (Oral Route) Before Using - Mayo Clinic

    Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

  4. Tofacitinib (Oral Route) Precautions - Mayo Clinic

    Precautions. Drug information provided by: Merative, Micromedex®. It is very important that your doctor check your progress at regular visits. This will ...

  5. Oncology (Medical) - Overview - Mayo Clinic

    Targeted drug therapy; Biological therapy; Chemotherapy; Hormone therapy; Supportive and Palliative Care Therapies; Experimental therapies; Other systemic ...

  6. Clonidine (Transdermal Route) Description and Brand Names - Mayo Clinic

    Clonidine belongs to the class of medicines called antihypertensives. It works in the brain to change some of the nerve impulses.

  7. Stopping Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients - Mayo Clinic

    ... treatment gaps of more than 12 weeks [84 days] between any two doses). Current Anti-Asthma Therapy: Asthma is currently being treated with a controller ...

  8. Influenza Virus Vaccine (Intradermal Route, Intramuscular Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. In 1976, a number of people who received the “swine flu” influenza vaccine ...

  9. Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction - Mayo Clinic

    Use of an investigational anti-cancer drug within 28 days preceding the first dose of dabrafenib; Patients receiving any medications or substances that are ...

  10. Ophthalmology News - Medical Professionals - Mayo Clinic

    Intravitreal anti-VEGF pharmacotherapy safe for treatment of diabetic macular edema. Study offers further evidence of a relatively safe systemic risk profile ...